A NEW LIGHT FOR GENOMIC DARK MATTER
Understanding disease requires more than just a genetic profile: Mutations are only a part of the story — often a smaller part than once thought. Many diseases, particularly the most devastating tumors and autoimmune diseases, are defined and driven not solely by DNA's sequence, but by it how is processed.
Our focus on epigenetic processes sheds light on the 'Genomic Dark Matter' absent from the understanding of disease, revealing critical pathways and leading to groundbreaking treatments.
Epigenome Technologies is the first to enable precise profiling of histone modifications and transcription factor binding at the single-cell level.
We are not just following the path of traditional genetic research; we are paving a new one.
Versatile Solutions for Every Researcher
Empowering your research with cutting-edge epigenetic solutions
Paired-Tag Kits
Innovative Assay Technology
Our proprietary Paired-Tag assays enable groundbreaking research into histone modifications, chromatin remodelers, and transcription factors.
Tailored for precision, our assays are designed to work seamlessly with your existing setup: platform-free, or compatible with the 10X Chromium system.
Comprehensive Servies
Full-Spectrum Research Support
We provide comprehensive support tailored to your research needs, from antibody selection and sample optimization to single-cell assays and advanced bioinformatics analysis.
Let us help you streamline your workflow and enhance your research outcomes.
Collaboration
Partnering for Progress
At Epigenome Technologies, we believe in the power of collaboration.
We partner with academic, nonprofit, and industry researchers to apply our single-cell epigenetic assays to drive discovery and innovation. Together, we can unlock the secrets of the epigenome.